Recasting natural product research

Terpenoid Therapeutics was recently mentioned in this Nature Biotechnology article:

By Cormac Sheridan

Can the commercial sector capitalize on the merger of high-throughput technology and natural products? Cormac Sheridan investigates.

The recent fanfare surrounding Warp Drive Bio, a startup with an ambitious agenda to marry natural products–based drug discovery with modern genomics, signals that there may still be life in what has become a moribund niche of the pharmaceutical industry. Although natural products research has historically been a mainstay of drug developers—
in previous eras, around half of all drugs had their origins in natural sources—interest in the area has dwindled in recent decades.

Get the full archived article…

Bookmark the permalink.

Comments are closed.